Capital Analysts LLC Has $35,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Capital Analysts LLC boosted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 938.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 457 shares of the company’s stock after purchasing an additional 413 shares during the period. Capital Analysts LLC’s holdings in GE HealthCare Technologies were worth $35,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cerity Partners LLC increased its holdings in GE HealthCare Technologies by 27.2% in the 4th quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock worth $3,551,000 after purchasing an additional 9,809 shares in the last quarter. Fifth Third Bancorp grew its position in shares of GE HealthCare Technologies by 3.9% in the 4th quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock valued at $2,600,000 after buying an additional 1,250 shares during the last quarter. Douglas Lane & Associates LLC grew its position in shares of GE HealthCare Technologies by 22.1% in the 4th quarter. Douglas Lane & Associates LLC now owns 436,253 shares of the company’s stock valued at $33,731,000 after buying an additional 79,073 shares during the last quarter. Prio Wealth Limited Partnership grew its position in shares of GE HealthCare Technologies by 25.1% in the 4th quarter. Prio Wealth Limited Partnership now owns 215,317 shares of the company’s stock valued at $16,648,000 after buying an additional 43,189 shares during the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in shares of GE HealthCare Technologies by 34.9% in the 3rd quarter. The Manufacturers Life Insurance Company now owns 341,769 shares of the company’s stock valued at $23,254,000 after buying an additional 88,384 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Down 0.6 %

GEHC stock opened at $84.49 on Friday. The stock’s 50 day simple moving average is $88.74 and its 200 day simple moving average is $77.82. GE HealthCare Technologies Inc. has a fifty-two week low of $62.35 and a fifty-two week high of $94.50. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The company has a market cap of $38.56 billion, a P/E ratio of 27.98, a price-to-earnings-growth ratio of 2.96 and a beta of 0.94.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share for the quarter, topping analysts’ consensus estimates of $1.07 by $0.11. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business had revenue of $5.20 billion for the quarter, compared to the consensus estimate of $5.09 billion. During the same period in the prior year, the business earned $1.31 EPS. The firm’s revenue for the quarter was up 5.3% on a year-over-year basis. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.97%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. Morgan Stanley upped their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research report on Monday, February 12th. Argus upped their price target on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, April 1st. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Mizuho upped their price target on GE HealthCare Technologies from $96.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, April 11th. Finally, UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and upped their target price for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $95.09.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.